Study on risku reducing mastectomy for NRCA1/2 mutation carriers

Study on risku reducing mastectomy for NRCA1/2 mutation carriers - Study on RRM for BRCA1/2 mutation carriers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021254

Enrollment

100

Registered

2016-04-01

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary breast and ovarian cancer

Interventions

risk reducing mastectomy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. BRCA1/2 mutant carriers 2. Informed consent

Exclusion criteria

Exclusion criteria: 1. Women with bilateral breast cancer 2. Physician decision

Design outcomes

Primary

Measure	Time frame
Perioperative complications related to risk reducing mastectomy	—

Countries

Japan

Contacts

Public Contacttetsu Hayashida

Keio University School of medicine Department of surgery

tetsu@z7.keio.jp+81-3-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026